OBJECTIVES: To determine whether offspring of parents with exceptional longevity (OPEL) have a lower rate of dementia than offspring of parents with usual survival (OPUS). DESIGN: Community-based prospective cohort study. SETTING: Bronx, New York. PARTICIPANTS: A volunteer sample of 424 community-residing older adults without dementia aged 75 to 85 recruited from Bronx County starting in 1980 and followed for up to 23 years. MEASUREMENTS: Epidemiological, clinical, and neuropsychological assessments were completed every 12 to 18 months. OPEL were defined as having at least one parent who reached the age of at least 85. OPUS were those for whom neither parent reached the age of 85. Dementia was diagnosed according to case conference consensus based on Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised, criteria without access to information on parental longevity. Alzheimer's disease was diagnosed using established criteria. RESULTS: Of 424 subjects, 149 (35%) were OPEL, and 275 (65%) were OPUS. Mean age at entry for both groups was 79. The OPEL group had a lower incidence of Alzheimer's disease (hazard ratio=0.57, 95% confidence interval=0.35-0.93). After adjusting for sex, education, race, hypertension, myocardial infarction, diabetes mellitus, and stroke, results were essentially unchanged. OPEL also had a significantly lower rate of memory decline on the Selective Reminding Test (SRT) than OPUS (P=.03). CONCLUSION: OPEL develop dementia and Alzheimer's disease at a significantly lower rate than OPUS. Demographic and medical confounders do not explain this result. Factors associated with longevity may protect against dementia and Alzheimer's disease.
OBJECTIVES: To determine whether offspring of parents with exceptional longevity (OPEL) have a lower rate of dementia than offspring of parents with usual survival (OPUS). DESIGN: Community-based prospective cohort study. SETTING: Bronx, New York. PARTICIPANTS: A volunteer sample of 424 community-residing older adults without dementia aged 75 to 85 recruited from Bronx County starting in 1980 and followed for up to 23 years. MEASUREMENTS: Epidemiological, clinical, and neuropsychological assessments were completed every 12 to 18 months. OPEL were defined as having at least one parent who reached the age of at least 85. OPUS were those for whom neither parent reached the age of 85. Dementia was diagnosed according to case conference consensus based on Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised, criteria without access to information on parental longevity. Alzheimer's disease was diagnosed using established criteria. RESULTS: Of 424 subjects, 149 (35%) were OPEL, and 275 (65%) were OPUS. Mean age at entry for both groups was 79. The OPEL group had a lower incidence of Alzheimer's disease (hazard ratio=0.57, 95% confidence interval=0.35-0.93). After adjusting for sex, education, race, hypertension, myocardial infarction, diabetes mellitus, and stroke, results were essentially unchanged. OPEL also had a significantly lower rate of memory decline on the Selective Reminding Test (SRT) than OPUS (P=.03). CONCLUSION: OPEL develop dementia and Alzheimer's disease at a significantly lower rate than OPUS. Demographic and medical confounders do not explain this result. Factors associated with longevity may protect against dementia and Alzheimer's disease.
Authors: Thomas T Perls; John Wilmoth; Robin Levenson; Maureen Drinkwater; Melissa Cohen; Hazel Bogan; Erin Joyce; Stephanie Brewster; Louis Kunkel; Annibale Puca Journal: Proc Natl Acad Sci U S A Date: 2002-06-11 Impact factor: 11.205
Authors: G L Burke; A M Arnold; D E Bild; M Cushman; L P Fried; A Newman; C Nunn; J Robbins Journal: J Am Geriatr Soc Date: 2001-03 Impact factor: 5.562
Authors: Terry Reed; Dorit Carmelli; Tiffany S Robinson; Shannon A Rinehart; Christopher J Williams Journal: J Gerontol A Biol Sci Med Sci Date: 2003-04 Impact factor: 6.053
Authors: Joe Verghese; Richard B Lipton; Charles B Hall; Gail Kuslansky; Mindy J Katz; Herman Buschke Journal: N Engl J Med Date: 2002-11-28 Impact factor: 91.245
Authors: Nir Barzilai; Gil Atzmon; Clyde Schechter; Ernst J Schaefer; Adrienne L Cupples; Richard Lipton; Suzanne Cheng; Alan R Shuldiner Journal: JAMA Date: 2003-10-15 Impact factor: 56.272
Authors: Ambarish Dutta; William Henley; Jean-Marie Robine; Kenneth M Langa; Robert B Wallace; David Melzer Journal: J Gerontol A Biol Sci Med Sci Date: 2013-05-16 Impact factor: 6.053
Authors: Marta Gonzalez-Freire; Alberto Diaz-Ruiz; David Hauser; Jorge Martinez-Romero; Luigi Ferrucci; Michel Bernier; Rafael de Cabo Journal: Ageing Res Rev Date: 2020-02-25 Impact factor: 10.895
Authors: Hermes Florez; Yong Ma; Jill P Crandall; Leigh Perreault; Santica M Marcovina; George A Bray; Christopher D Saudek; Elizabeth Barrett-Connor; William C Knowler Journal: J Gerontol A Biol Sci Med Sci Date: 2011-08-17 Impact factor: 6.053
Authors: Aladdin H Shadyab; JoAnn E Manson; Wenjun Li; Margery Gass; Robert L Brunner; Michelle J Naughton; Brad Cannell; Barbara V Howard; Andrea Z LaCroix Journal: Age Ageing Date: 2018-11-01 Impact factor: 10.668
Authors: Joanne M Murabito; Alexa S Beiser; Charles Decarli; Sudha Seshadri; Philip A Wolf; Rhoda Au Journal: Age Ageing Date: 2013-11-07 Impact factor: 10.668
Authors: Dana P Goldman; David Cutler; John W Rowe; Pierre-Carl Michaud; Jeffrey Sullivan; Desi Peneva; S Jay Olshansky Journal: Health Aff (Millwood) Date: 2013-10 Impact factor: 6.301